FIELD: chemistry.
SUBSTANCE: present invention relates to novel derivatives of 1-(3-aminophenyl)-6,8-dimethyl-5-(4-iodo-2-fluoro-phenylamino)-3-cyclopropyl-1H, 6H-pyrido[4,3-d]pyrimidine-2,4,7-trione, having effect on kinase MEK1 and can be used for treating and preventing cancer, in particular malignant melanoma. Said derivatives are selected from following group of compounds: N-{3-[6,8-dimethyl-5-(4-iodo-2-fluoro-phenylamino)-3-cyclopropyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]-phenyl}-2-dimethylaminoacetamide hydrochloride (1.1), N-{3-[6,8-dimethyl-5-(4-iodo-2-fluoro-phenylamino)-3-cyclopropyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]-phenyl}-2-dimethylaminopropionamide hydrochloride (1.4), N-{3-[6,8-dimethyl-5-(4-iodo-2-fluoro-phenylamino)-3-cyclopropyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]-phenyl}-2-dimethylaminobutyramide hydrochloride (1.7), (R)-{3-[6,8-dimethyl-5-(4-iodo-2-fluoro-phenylamino)-3-cyclopropyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]-phenyl}-2-dimethylaminopropionamide hydrochloride (1.10), {3-[6,8-dimethyl-5-(4-iodo-2-fluoro-phenylamino)-3-cyclopropyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]-phenyl}-amide(R)-1-methylpyrrolidine-2-carboxylic acid hydrochloride (1.14). Invention also relates to a method of producing said compounds.
EFFECT: method consists in that compound of formula 2 or salt thereof: , where R2 is a hydrogen atom, reacts with corresponding organic acid or an activated derivative thereof, with subsequent treatment of obtained product with hydrogen chloride solution.
11 cl, 1 tbl, 7 ex
Title |
Year |
Author |
Number |
N-{3-[3-CYCLOPROPYL-5-(2-FLUORO-4-IODOPHENYLAMINO)-6,8-DIMETHYL-2,4,7-TRIOXO-3,4,6,7-TETRAHYDRO-2H-PYRIDO[4,3-D]PYRIMIDINE-1-IL]-PHENYL}-CYCLOPROPANECARBOXAMIDE DIMETHYLSULFOXIDE SOLVATE AS MEK1/2 INHIBITOR |
2016 |
- Ivashchenko Aleksandr Vasilevich
- Ignatev Vasilij Gennadevich
- Repik Aleksej Evgenevich
- Shafeev Mikhail Ajratovich
|
RU2627692C1 |
SUBSTITUTED N-{3-[4-(1-METHYL-1H-INDOL-3-YL)PYRIMIDIN-2-YLAMINO]-4-METHOXYPHENYL}-AMIDES AS MODULATORS OF EGFR, APPLICABLE FOR TREATING CANCER |
2015 |
- Ivashchenko Aleksandr Vasilevich
- Ignatev Vasilij Gennadevich
- Repik Aleksej Evgenevich
- Shafeev Mikhail Ajratovich
|
RU2606949C9 |
SUBSTITUTED METHYL(2-{4-[3-(3-METHANESULFONYLAMINO-2-FLUORO-5-CHLORO-PHENYL)-1H-PYRAZOL-4-YL]PYRIMIDIN-2-YLAMINO}ETHYL) CARBAMATES, PROCESS FOR THEIR PREPARATION AND APPLICATION |
2016 |
- Ivashchenko Aleksandr Vasilevich
- Ignatev Vasilij Gennadevich
- Repik Aleksej Evgenevich
- Shafeev Mikhail Ajratovich
|
RU2615986C1 |
SUBSTITUTED N2-(4-AMINO-2-METHOXYPHENYL)-N4-[2-(DIMETHYLPHOSPHORYL)-PHENYL]-5-CHLORO-PYRIMIDINE-2,4-DIAMINES AS MODULATORS OF ALK AND EGFR, APPLICABLE FOR TREATING CANCER |
2015 |
- Ivashchenko Aleksandr Vasilevich
- Ignatev Vasilij Gennadevich
- Repik Aleksej Evgenevich
- Shafeev Mikhail Ajratovich
|
RU2607371C1 |
DICHLOROACETATES OF SUBSTITUTED N4-[2-(DIMETHYLPHOSPHORYL)PHENYL]-N2-(2-METHOXY-4-PIPERIDIN-1-YLPHENYL)-5-CHLOROPYRIMIDINE-2,4-DIAMINES AS MODULATORS OF ALK AND EGFR, INTENDED FOR TREATING CANCER |
2015 |
- Ivashchenko Aleksandr Vasilevich
- Ignatev Vasilij Gennadevich
- Repik Aleksej Evgenevich
- Shafeev Mikhail Ajratovich
|
RU2606951C1 |
8-(1-{4-{(5-CHLORO-4-{(2-(DIMETHYLPHOSPHORYL)PHENYL)AMINO}PYRIMIDIN-2-YL)AMINO)-3-METHOXYPHENYL}PIPERIDIN-4-YL)-1-METHYL-1,8-DIAZASPIRO(4.5)DECAN-2-ONE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS AS AN ALK AND EGER MODULATOR FOR TREATMENT OF CANCER |
2017 |
- Ivashchenko Aleksandr Vasilevich
- Ignatev Vasilij Gennadevich
- Repik Aleksej Evgenevich
- Shafeev Mikhail Ajratovich
|
RU2654695C1 |
{3-[(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)AZOLYL]AZETIDIN-3-YL} ACETONITRILES AS JANUS KINASE INHIBITORS |
2015 |
- Ivashchenko Aleksandr Vasilevich
- Ignatev Vasilij Gennadevich
- Repik Aleksej Evgenevich
- Shafeev Mikhail Ajratovich
|
RU2601410C1 |
PYRIDYL KETONE DERIVATIVES, METHOD OF PREPARING SAME AND PHARMACEUTICAL APPLICATION THEREOF |
2014 |
- Tu Vanyan
- Chzhan Khajtan
- Syuj Gotszi
- Chi Tszyantao
|
RU2667892C2 |
DICHLOROACETATE OF N,N-DISUBSTITUTED N-[4-(1-METHYL-1H-INDOLE-3-YL)-PYRIMIDINE-2-YL]-5-METHOXYBENZENE-1,2,4-TRIAMINE AS EGFR MODULATOR FOR TREATING CANCER |
2015 |
- Ivashchenko Aleksandr Vasilevich
- Ignatev Vasilij Gennadevich
- Repik Aleksej Evgenevich
- Shafeev Mikhail Ajratovich
|
RU2603960C1 |
PRODRUG OF TRIAZOLONE COMPOUND |
2011 |
- Klark Richard
- Matsuura Fumiesi
- Sinoda Masanobu
- Khirota Sinsuke
- Kira Kazunobu
- Azuma Khirosi
- Takemura Atsusi
- Jasui So
- Kusano Kazutomi
- Mikamoto Masaki
- Omae Takao
|
RU2581369C2 |